We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1860:TSEMobvista Inc. Analysis

Data as of 2026-03-16 - not real-time

HK$16.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mobvista Inc. is trading well above its 20‑day (13.20), 50‑day (14.73) and 200‑day (13.65) simple moving averages, and the MACD histogram is positive, indicating a short‑term bullish momentum. The RSI sits at 63, comfortably below the overbought threshold, while volume is on an upward trend, supporting the technical upside. However, the stock’s trailing P/E of 80.5 dwarfs the industry average of 17.8, and a price‑to‑book of nearly 11 suggests the market is pricing in significant growth expectations. Revenue is expanding at a robust 27% year‑over‑year, yet operating margins are thin (≈4.6%) and cash‑flow generation is currently flat, raising questions about sustainability. The forward P/E of 16.8 aligns more closely with peers, and analysts collectively rate the stock as a strong buy with a median target of HK$20, implying modest upside from the current HK$16.1 level. Volatility is extremely high (≈81% over 30 days) but beta is low (≈0.4), indicating the stock moves sharply but is less correlated with the broader market. Overall, the blend of bullish technicals, strong top‑line growth, and elevated valuation creates a nuanced risk‑reward profile.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and positive histogram
  • RSI in a healthy range with rising volume
  • Price above key moving averages

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 27% revenue growth and improving forward earnings
  • Analyst consensus of strong‑buy with median target HK$20
  • Forward P/E of 16.8 aligns with industry norms

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Current valuation multiples remain stretched
  • Flat operating cash flow and modest profit margins
  • High volatility and sector cyclicality

Key Metrics & Analysis

Financial Health

Revenue Growth27.40%
Profit Margin3.01%
P/E Ratio80.5
ROE23.76%
ROA7.54%
Debt/Equity8.00
P/B Ratio11.0
Industry P/E17.8

Technical Analysis

TrendNeutral
RSI62.9
SupportHK$11.27
ResistanceHK$18.20
MA 20HK$13.20
MA 50HK$14.73
MA 200HK$13.65
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target PriceHK$17.17
Upside/Downside6.67%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.39
Volatility81.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.